JP2011516459A5 - - Google Patents

Download PDF

Info

Publication number
JP2011516459A5
JP2011516459A5 JP2011502439A JP2011502439A JP2011516459A5 JP 2011516459 A5 JP2011516459 A5 JP 2011516459A5 JP 2011502439 A JP2011502439 A JP 2011502439A JP 2011502439 A JP2011502439 A JP 2011502439A JP 2011516459 A5 JP2011516459 A5 JP 2011516459A5
Authority
JP
Japan
Prior art keywords
acid
amino acid
salt
pregabalin
enantiomerically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011502439A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011516459A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2009/050326 external-priority patent/WO2009122215A1/en
Publication of JP2011516459A publication Critical patent/JP2011516459A/ja
Publication of JP2011516459A5 publication Critical patent/JP2011516459A5/ja
Withdrawn legal-status Critical Current

Links

JP2011502439A 2008-04-04 2009-04-02 新規な方法 Withdrawn JP2011516459A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN679/KOL/2008 2008-04-04
IN679KO2008 2008-04-04
PCT/GB2009/050326 WO2009122215A1 (en) 2008-04-04 2009-04-02 Novel process

Publications (2)

Publication Number Publication Date
JP2011516459A JP2011516459A (ja) 2011-05-26
JP2011516459A5 true JP2011516459A5 (enExample) 2012-05-24

Family

ID=40674128

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011502439A Withdrawn JP2011516459A (ja) 2008-04-04 2009-04-02 新規な方法

Country Status (8)

Country Link
US (1) US20110124909A1 (enExample)
EP (1) EP2262761A1 (enExample)
JP (1) JP2011516459A (enExample)
CN (1) CN102089273A (enExample)
AU (1) AU2009233536A1 (enExample)
CA (1) CA2719892A1 (enExample)
NZ (1) NZ588894A (enExample)
WO (1) WO2009122215A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2412700B1 (en) 2009-03-26 2016-11-09 Daiichi Sankyo Company, Limited Method for producing bicyclic gamma-amino acid derivative
HUP1000186A2 (en) 2010-04-08 2011-10-28 Richter Gedeon Nyrt Novel industrial process of preparing (s)-(+) pregabalin
KR20130138770A (ko) * 2010-09-01 2013-12-19 아레나 파마슈티칼스, 인크. 광학적으로 활성 산을 갖는 로르카세린의 염
EP2527319A1 (en) * 2011-05-24 2012-11-28 Laboratorios Del. Dr. Esteve, S.A. Crystalline forms of pregabalin and co-formers in the treatment of pain
CA2888877C (en) 2012-11-07 2021-07-27 Hikal Limited A process for the preparation of pregabalin
CN105085290A (zh) * 2015-08-18 2015-11-25 太仓运通生物化工有限公司 一种合成普瑞巴林的方法
CN105348124A (zh) * 2015-11-26 2016-02-24 太仓运通生物化工有限公司 一种以氧代吡咯烷为中间体合成普瑞巴林的方法
CN108456144A (zh) * 2017-11-03 2018-08-28 乳源东阳光药业有限公司 一种小粒径晶状普瑞巴林、组合物及其制备工艺
CN113801031B (zh) * 2021-10-26 2023-12-26 浙江华海药业股份有限公司 一种普瑞巴林的纯化方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637767A (en) * 1995-06-07 1997-06-10 Warner-Lambert Company Method of making (S)-3-(aminomethyl)-5-methylhexanoic acid
US20060270871A1 (en) * 2005-05-30 2006-11-30 Khanduri Chandra H Polymorphic form i of pregabalin and processes for its preparation
EP1736462A1 (en) * 2005-06-22 2006-12-27 Sandoz AG Recovery of optically active tartaric acid resolving agents
WO2008117305A2 (en) * 2007-03-28 2008-10-02 Glenmark Pharmaceuticals Limited A novel process for preparing pregabalin and its acid addition salts
WO2008138874A1 (en) * 2007-05-09 2008-11-20 Chemo Ibérica, S.A. Process for preparing (s)-pregabalin by optical resolution of racemic pregabalin
WO2009001372A2 (en) * 2007-06-25 2008-12-31 Manne Satyanarayana Reddy A novel process for the preparation of pregabalin
WO2009044409A2 (en) * 2007-10-01 2009-04-09 Natco Pharma Limited Novel resolution process for pregabalin

Similar Documents

Publication Publication Date Title
JP2011516459A5 (enExample)
JP5319885B2 (ja) モナティンの製造方法
JP2012526791A5 (enExample)
JP2011516459A (ja) 新規な方法
JPS6320217B2 (enExample)
EP1841726B1 (en) An asymmetric synthesis of (s)-(+)-3-(aminomethyl)-5-methylhexanoic acid
EP1224161B1 (en) Nitroxy derivatives of (r) and (s)-carnitine
US6051734A (en) Process for the optical resolution of 3-(p-chlorophenyl)-glutaramide
CN103073483B (zh) 一种甲哌卡因及其光学对映体的制备方法
CN102093254B (zh) 一种二水合3-(2,2,2-三甲基肼)丙酸盐的制备方法
US20160304452A1 (en) Method for preparing silodosin and intermediate thereof
CA2856666A1 (en) Novel process for racemization of an optically active (s)-3-carbamoylmethyl-5-methyl-hexanoic acid to corresponding 3-carbamoylmethyl-5-methyl-hexanoic acid racemate
JP2007191470A (ja) 光学活性2−アミノブタンアミドもしくはその塩の製造方法
WO2013058241A1 (ja) (r)-2-アミノ-2-エチルヘキサノールの製造法
JP5510040B2 (ja) 光学活性(r)−1−(4−フルオロフェニル)エチルアミンを得る光学分割
CZ2006773A3 (cs) Zpusob cištení hydrochloridu (S)-N-methyl-3-(1-naftyloxy)-3-(2-thienyl)propylaminu (duloxetinu)
US20110144383A1 (en) Process for preparing (s)-3-(aminomethyl)-5-methylhexanoic acid
JP4752285B2 (ja) トリフルオロ乳酸の効率的な光学分割
JP3847934B2 (ja) γ−オキソ−ホモフェニルアラニン誘導体及びそれを還元してなるホモフェニルアラニン誘導体の製造方法
JP4166987B2 (ja) 光学活性化合物の製法
JP2002003453A (ja) 光学活性α−メチル−ビス−3,5−(トリフルオロメチル)ベンジルアミン類の精製方法
CN100361963C (zh) 不对称转换法制备d-丙氨酸的方法
JP2003238506A (ja) 光学活性なβ−フェニルアラニン誘導体の製造方法
CN116693409A (zh) 一种(2s)-[4-(3-氟苄氧基)苄胺基]丙酸甲酯的制备方法
WO2013089189A1 (ja) ヒドロキシスルホン酸を経由する二環性化合物の光学分割方法